Pratz, Keith W., Jason Kaplan, Moshe Levy, Dale Bixby, Patrick W. Burke, Harry Erba, Trisha M. Wise-Draper, Gail J. Roboz, Nikolaos Papadantonakis, Trivikram Rajkhowa, Daniela Hernandez, Iwona Dobler, Richard C. Gregory, Cheryl Li, Shining Wang, Kate Stumpo, Karuppiah Kannan, Harry Miao, and Mark Levis. 2022. “A Phase Ib Trial of Mivavotinib (TAK-659), a Dual SYK/FLT3 Inhibitor, in Patients With relapsed/Refractory Acute Myeloid Leukemia”. Haematologica 108 (3). Pavia, Italy, 705-16. https://doi.org/10.3324/haematol.2022.281216.